The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Volkova E.V.

Kafedra akusherstva i ginekologii lechebnogo fakul'teta Rossiĭskogo gosudarstvennogo meditsinskogo universiteta

Lysiuk E.Iu.

Laboratoriia gennoĭ terapii Instituta biologii gena RAN, Moskva

Vinokurova I.N.

Kafedra akusherstva i ginekologii lechebnogo fakul'teta Rossiĭskogo gosudarstvennogo meditsinskogo universiteta im. N.I. Pirogova, Moskva

Dzhokhadze L.S.

Kafedra akusherstva i ginekologii lechebnogo fakul'teta Rossiĭskogo gosudarstvennogo meditsinskogo universiteta

THE ROLE OF VASCULAR GROWTH FACTORS IN THE DIAGNOSIS OF VARIOUS FORMS OF HYPERTENSION IN PREGNANCY

Authors:

Volkova E.V., Lysiuk E.Iu., Vinokurova I.N., Dzhokhadze L.S.

More about the authors

Read: 701 times


To cite this article:

Volkova EV, Lysiuk EIu, Vinokurova IN, Dzhokhadze LS. THE ROLE OF VASCULAR GROWTH FACTORS IN THE DIAGNOSIS OF VARIOUS FORMS OF HYPERTENSION IN PREGNANCY. Russian Journal of Human Reproduction. 2012;(6):63‑67. (In Russ.)

References:

  1. Bogdanov S.V., Zhavoronkova E.Yu., Volkova E.G. Geterogennost' gipertenzivnykh sostoyanii u beremennykh. Ural'skii s''ezd kardiologov, 4-i: Materialy. Khanty-Mansiisk 2009; 23-25.
  2. Villar J., Say L., Gulmezoglu A.M., Merialdi M., Lindheimer M., Beltran A.P. et al. Eclampsia and preeclampsia: a worldwide health problem for 2000 years. In Preeclampsia. Eds. H. Critchley, A. Maclean, L. Poston, J. Walker. London: RCOG 2003.
  3. Gifford R.W., August P.A., Cunningham G. Working Group Report on High Blood Pressure. Pregnancy 2006; 38.
  4. Mozgovaya E.V., Malysheva O.V., Ivashchenko T.E. i dr. Endotelial'naya disfunktsiya pri gestoze. Patogenez, geneticheskaya predraspolozhennost', diagnostika i profilaktika: Metodicheskie rekomendatsii. SPb 2003.
  5. Chulkov V.S. Osobennosti techeniya i iskhodov beremennosti u zhenshchin s razlichnymi formami arterial'noi gipertenzii. Asp vestn Povolzh'ya 2009; 7-8: 75-79.
  6. Makarov O.V., Tkacheva O.N., Volkova E.V. Preeklampsiya i khronicheskaya arterial'naya gipertenziya u beremennykh. Rukovodstvo dlya vrachei 2010; 131.
  7. Buhimschi C.S., Norwitz E.R., Funai E., Richman S., Guller S., Lockwood C.J., Buhimschi I.A. Urinary angiogenic factors cluster hypertensive disorders and identify women with severe preeclampsia. Am J Obstet Gynecol 2005; 192: 734-741.
  8. Lam C., Lim K.H., Karumanchi S.A. Circulating angiogenic factors in the pathogenesis and prediction of preeclampsia. Hypertension 2005; 46: 1077-1085.
  9. Levine R.J., Lam C., Qian C. et al. Soluble endoglin and other circulating antiangiogenic factors in preeclampsia. N Engl J Med 2006; 355: 10: 992-1005.
  10. Verlohren S. et al. The sFlt-1/PlGF ratio in different types of hypertensive pregnancy disorders and its prognostic potential in preeclamptic patients. Am J Obstet Gynecol 2012; 206: 1: 58: e1-e8.
  11. Masuyama H. et al. Different profiles of circulating angiogenic factors and adipocytokines between early- and late-onset pre-eclampsia. BJOG 2010; 117: 3: 314-320.
  12. The Task Force for the management of arterial hypertension of the European Society of Hypertension and of the European Society of Cardiolody. 2007 Guidelines for the management of arterial hypertension. J Hypertens 2007; 25: 1105-1187.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.